JAGUAR HEALTH, INC. Debt Instrument, Face Amount
JAGUAR HEALTH, INC. (JAGX) had Debt Instrument, Face Amount of $350.00 thousand as of 2020-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2021-11-17
- 2020-03-31: Debt Instrument, Face Amount $350.00K.
- 2019-10-31: Debt Instrument, Face Amount $550.00K.
- 2019-03-18: Debt Instrument, Face Amount $5.10M.
- 2016-12-31: Debt Instrument, Face Amount $12.50M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-03-31 | $350.00K 10-Q · filed 2021-05-17 |
| 2019-10-31 | $550.00K 10-K · filed 2020-04-03 |
| 2019-03-18 | $5.10M 10-Q · filed 2021-11-17 |
| 2016-12-31 | $12.50M 10-Q · filed 2020-11-16 |
| 2016-07-31 | $150.00K 10-Q · filed 2017-11-20 |
| 2015-02-28 | $150.00K 10-Q · filed 2019-11-14 |
| 2014-06-02 | $300.00K 10-K · filed 2017-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |